244 related articles for article (PubMed ID: 31983108)
21. XRCC1 rs25487 polymorphism predicts the survival of patients after postoperative radiotherapy and adjuvant chemotherapy for breast cancer.
Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
Anticancer Res; 2014 Jun; 34(6):3031-7. PubMed ID: 24922669
[TBL] [Abstract][Full Text] [Related]
22. Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
Breaux A; Turner B; Wu X; Rai SN; Riley EC; Mandadi M; Sanders MA
Clin Breast Cancer; 2019 Feb; 19(1):e261-e269. PubMed ID: 30509870
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India.
Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
Tumour Biol; 2014 Nov; 35(11):11171-81. PubMed ID: 25106408
[TBL] [Abstract][Full Text] [Related]
24. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women.
Datta A; Tuz Zahora F; Abdul Aziz M; Sarowar Uddin M; Ferdous M; Shalahuddin Millat M; Shahid Sarwar M; Abdul Barek M; Jafrin S; Nahar S; Safiqul Islam M
Int Immunopharmacol; 2020 Dec; 89(Pt B):107091. PubMed ID: 33069925
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.
Anghel A; Raica M; Narita D; Seclaman E; Nicola T; Ursoniu S; Anghel M; Popovici E
Neoplasma; 2010; 57(4):306-15. PubMed ID: 20429621
[TBL] [Abstract][Full Text] [Related]
26. Opposite Prognostic Impact of Single PTEN-loss and
Lazaridis G; Kotoula V; Vrettou E; Kostopoulos I; Manousou K; Papadopoulou K; Giannoulatou E; Bobos M; Sotiropoulou M; Pentheroudakis G; Efstratiou I; Papoudou-Bai A; Psyrri A; Christodoulou C; Gogas H; Koutras A; Timotheadou E; Pectasides D; Zagouri F; Fountzilas G
Cancer Genomics Proteomics; 2019; 16(3):195-206. PubMed ID: 31018950
[TBL] [Abstract][Full Text] [Related]
27. MiR-4728-3p could act as a marker of HER2 status.
Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.
Kasamatsu T; Saitoh T; Ino R; Gotoh N; Mitsui T; Shimizu H; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Murakami H
Hematol Oncol; 2017 Dec; 35(4):711-718. PubMed ID: 27405747
[TBL] [Abstract][Full Text] [Related]
29. Association of rs1946518 C/A Polymorphism in Promoter Region of Interleukin 18 Gene and Breast Cancer Risk in Iranian Women: A Case-control Study.
Fathi Maroufi N; Aghayi E; Garshasbi H; Gholampour Matin M; Babazadeh Bedoustani A; Firouzi Amoudizaj F; Hajazimian S; Isazadeh A; Taefehshokr S; Taefehshokr N; Baradaran B
Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):671-678. PubMed ID: 32245311
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.
Wang Z; Liu QL; Sun W; Yang CJ; Tang L; Zhang X; Zhong XM
Croat Med J; 2014 Dec; 55(6):638-46. PubMed ID: 25559835
[TBL] [Abstract][Full Text] [Related]
31. Role of ATG16LI (rs2241880) and Interleukin 10 (rs1800872) Polymorphisms in Breast Cancer Among Egyptian Patients.
El-Amir MI; Wahman MM; Khaled HA; El-Feky MA
Egypt J Immunol; 2020 Jan; 27(1):65-76. PubMed ID: 33180389
[TBL] [Abstract][Full Text] [Related]
32. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
33. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
34. The rs2234694 and 50 bp Insertion/Deletion polymorphisms of the SOD1 gene are associated with breast cancer risk in a Mexican population.
Gallegos-Arreola MP; Ramírez-Hernández MA; Figuera LE; Zúñiga-González GM; Puebla-Pérez AM
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8017-8027. PubMed ID: 32767328
[TBL] [Abstract][Full Text] [Related]
35. The rs1008562, rs2234671, and rs3138060 polymorphisms of the CXCR1 gene are associated with breast cancer risk in a Mexican population.
Gallegos-Arreola MP; Briseño-Zuno CJ; Figuera LE; Sánchez-López JY; Zúñiga-González GM; Puebla-Pérez AM; Gómez-Meda BC; Montoya-Fuentes H; Delgado-Saucedo JI
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9990-10002. PubMed ID: 33090404
[TBL] [Abstract][Full Text] [Related]
36. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
37. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
38. Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy.
Park KU; Chen Y; Chitale D; Choi S; Ali H; Nathanson SD; Bensenhaver J; Proctor E; Petersen L; Loutfi R; Simonds A; Kuklinski M; Doyle T; Dabak V; Cole K; Davis M; Newman L
Ann Surg Oncol; 2018 Jul; 25(7):1921-1927. PubMed ID: 29679201
[TBL] [Abstract][Full Text] [Related]
39. Association between Genetic Polymorphisms of miR-1307, miR- 1269, miR-3117 and Breast Cancer Risk in a Sample of South East Iranian Women.
Sarabandi S; Sattarifard H; Kiumarsi M; Karami S; Taheri M; Hashemi M; Bahari G; Ghavami S
Asian Pac J Cancer Prev; 2021 Jan; 22(1):201-208. PubMed ID: 33507700
[TBL] [Abstract][Full Text] [Related]
40. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
